Mizoribine
SIGMA/M3047 - ≥98% (TLC)
Synonym: N′-(β-D-Ribofuranosyl)-5-hydroxyimidazole-4-carboxamide
CAS Number: 50924-49-7
Empirical Formula (Hill Notation): C9H13N3O6
Molecular Weight: 259.22
MDL Number: MFCD00057221
Linear Formula: C9H13N3O6
Product Type: Chemical
| assay | ≥98% (TLC) |
| InChI | 1S/C9H13N3O6/c10-7(16)4-8 |
| InChI key | HZQDCMWJEBCWBR-UUOKFMHZSA |
| Quality Level | 200 ![]() |
| SMILES string | NC(=O)c1ncn([C@@H]2O[C@H] |
| storage temp. | 2-8°C |
| Application: | Mizoribine has been used in topical treatment to evaluate its effect on ocular surface damage of dry eye in B6 mice subjected to desiccating stress (DS). It has also been used as an inosine monophosphate dehydrogenase (IMPDH) inhibitor to test its in vivo efficacy. |
| Biochem/physiol Actions: | Mizoribine is an imidazole nucleoside possessing strong immunosuppressive properties. It selectively blocks T-cell proliferation response to mitogenic and allo-antigenic stimulation. Mizoribine blocks the movement of T cells from G to S phase. In addition, it significantly decreases the number of B cells at the S, G, and M phases. Mizoribine inhibits de novo synthesis of nucleotides by inhibition of inosine monophosphate dehydrogenase. The resulting nucleotide depletion inhibits DNA synthesis.(3) |
| Packaging: | 10 mg in poly bottle |
| Packaging: | 25 mg in glass bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H315 - H319 - H335 - H360 |
| Precautionary statements | P201 - P302 + P352 - P305 + P351 + P338 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 46-60-61-36/37/38 |
| Safety Statements | 53-22-26-36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (TLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |



